Given this mix of lower rates, a strong stock market, and lingering uncertainties, how should investors balance risk and return in their portfolios for the rest of the year?
And if you wanted to skip complicated products like ILP's, what would alternative options be?
Michelle Martin finds out with Cheng Chye Hsern, Head of Investment, Providend.

Money and Me: Are you insured for a specific illness or how a policy defines an illness and its treatment?
26:51

Market View: Oil whipsaws on peace hopes, AI Moves - Meta, Grab, Delta in Focus
25:08

Market View: Ceasefire Relief, Oil Swings & the SpaceX IPO Frenzy
23:49